Physician-Patient Communication Project
1 other identifier
observational
456
1 country
5
Brief Summary
Over half of all Americans take dietary supplements (vitamins, minerals, herbal products) along with their prescription medications. With the economic downturn, dietary supplement sales have surged, perhaps as a result of people attempting to stave off or delay medical care. Supplements are generally thought to be harmless, but some can potentially interact with prescription medications, cause liver or kidney damage, and even adversely affect surgical outcomes. Those substituting dietary supplements for prescription medications also may suffer significant adverse consequences. The United States Food and Drug Administration and the Institute of Medicine recommend that patients considering dietary supplement use consult their providers. Unfortunately, patients fail to disclose dietary supplement use in up to two-thirds of outpatient office visits. To improve discussions, it is important to understand what prompts physicians and patients to communicate about dietary supplements. The overall objectives of this application are to understand how, when and why physicians and patients communicate about dietary supplements, and to assess how patients respond to these discussions. An ethnically diverse group of patients and their physicians will be surveyed and their office visits will be audio recorded. Audio recordings of the visits will be used to assess the relationship of patient and physician attitudes and values, and the physician-patient relationship on dietary supplement discussions. A subset of these patients and physicians will be interviewed to explore how they made decisions to initiate or forgo discussions about supplements. They also will be asked questions concerning the necessity of and responsibility for initiating dietary supplement conversations. Patient responses and reactions to actual discussions also will be explored. Data from observed and reported interactions will be compared to provide a deeper understanding of factors related to disclosure. This project aims to provide a broad understanding of the content of physician-patient discussions about dietary supplements, and to describe how and why physician and patient attitudes and opinions affect these discussions. Identification of mutable factors can result in interventions to increase communication about dietary supplements, help maintain patient safety, and promote appropriate use of supplements concurrent with prescription medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2011
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 2, 2012
CompletedFirst Posted
Study publicly available on registry
February 10, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedJune 6, 2013
June 1, 2013
1.5 years
January 2, 2012
June 5, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
patients disclosing dietary supplement use
Number of patients who disclosed dietary supplement use during audio recorded office visit
Disclosure will be measured at a single time point - on the day the patient's office visit is audio recorded. A subset of patients will be selected for a semi-structured interview up to 1 week after the visit.
Eligibility Criteria
Primary care physicians Integrative medicine / complementary and alternative medicine physicians Patients aged 18 and older of physicians participating in the study
You may qualify if:
- English or Spanish-speaking
- Aged 18 and older
You may not qualify if:
- Does not speak English or Spanish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Kaiser Permanente LAMC
Los Angeles, California, 90027, United States
Center for East-West Medicine
Los Angeles, California, 90404, United States
LA Net Practice Based Research Network
Los Angeles, California, 90808, United States
Community-based provider offices
Los Angeles, California, United States
University of California, Los Angeles
Santa Monica, California, 90404, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Derjung M Tarn, MD, PhD
University of California, Los Angeles
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 2, 2012
First Posted
February 10, 2012
Study Start
November 1, 2011
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
June 6, 2013
Record last verified: 2013-06